Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$244M |
| 2 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$143M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$137M |
| 4 |
iShares MSCI EAFE ETF
EFA
|
+$109M |
| 5 |
VMW
VMware, Inc
VMW
|
+$103M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.2B |
| 2 |
Apple
AAPL
|
+$763M |
| 3 |
Microsoft
MSFT
|
+$618M |
| 4 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$592M |
| 5 |
AABA
Altaba Inc
AABA
|
+$393M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.41% |
| 2 | Healthcare | 5.88% |
| 3 | Financials | 5.51% |
| 4 | Consumer Discretionary | 4.79% |
| 5 | Communication Services | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4801
iShares MSCI Turkey ETF
TUR
$213M
| $163K | ﹤0.01% |
5,397
+119
| +2% | +$4.13K |
|
|
AUTL
4802
Autolus Therapeutics
AUTL
$551M
| $162K | ﹤0.01% |
+6,052
| New | +$160K |
|
|
CRESY
4803
Cresud
CRESY
$772M
| $162K | ﹤0.01% |
12,164
+5,828
| +92% | +$95.8K |
|
4804
CALL
Direxion Daily Energy Bear 2X ETF
ERY
$41.8M
| $162K | ﹤0.01% |
490
+388
| +380% | +$144K |
|
4805
Liberty Latin America Class C
LILAK
$1.67B
| $162K | ﹤0.01% |
9,758
+9,154
| +1,516% | +$160K |
|
4806
Ocular Therapeutix
OCUL
$1.95B
| $162K | ﹤0.01% |
24,092
-4,170
| -15% | -$28.6K |
|
4807
PUT
Brighthouse Financial
BHF
$3.57B
| $161K | ﹤0.01% |
4,014
-405
| -9% | -$19.5K |
|
4808
PUT
Beazer Homes USA
BZH
$904M
| $161K | ﹤0.01% |
10,900
+5,600
| +106% | +$86.1K |
|
4809
Cenntro
CENN
$8.23M
| – | – |
0
| – | – |
|
4810
National Vision
EYE
$1.8B
| $161K | ﹤0.01% |
4,406
-5,084
| -54% | -$177K |
|
4811
HNI Corp
HNI
$3.53B
| $161K | ﹤0.01% |
4,338
-10,164
| -70% | -$371K |
|
4812
Kadant
KAI
$3.94B
| $161K | ﹤0.01% |
1,685
-3,019
| -64% | -$290K |
|
4813
MGE Energy Inc
MGEE
$3.05B
| $161K | ﹤0.01% |
2,558
-7,113
| -74% | -$415K |
|
4814
CALL
O-I Glass
OI
$1.11B
| $161K | ﹤0.01% |
9,600
+600
| +7% | +$11.6K |
|
4815
abrdn Physical Gold Shares ETF
SGOL
$7.43B
| $161K | ﹤0.01% |
13,300
| – | – |
|
4816
PUT
Vicor
VICR
$10.3B
| $161K | ﹤0.01% |
3,700
+400
| +12% | +$15.5K |
|
4817
CALL
Community Health Systems
CYH
$415M
| $160K | ﹤0.01% |
48,100
-3,400
| -7% | -$14.4K |
|
4818
PUT
Pediatrix Medical
MD
$2.15B
| $160K | ﹤0.01% |
3,700
-13,300
| -78% | -$637K |
|
4819
QuidelOrtho
QDEL
$882M
| $160K | ﹤0.01% |
2,401
-8,194
| -77% | -$495K |
|
4820
Rocket Pharmaceuticals
RCKT
$391M
| $160K | ﹤0.01% |
8,156
-27,944
| -77% | -$529K |
|
|
MTOR
4821
CALL
DELISTED
MERITOR, Inc.
MTOR
| $160K | ﹤0.01% |
7,800
-5,900
| -43% | -$124K |
|
4822
Evolus
EOLS
$482M
| $159K | ﹤0.01% |
5,708
+4,363
| +324% | +$77K |
|
4823
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$723M
| $159K | ﹤0.01% |
3,585
| – | – |
|
4824
Prudential
PUK
$36B
| $159K | ﹤0.01% |
+3,598
| New | +$176K |
|
4825
PUT
ProShares Ultra Russell2000
UWM
$247M
| $159K | ﹤0.01% |
4,000
+3,800
| +1,900% | +$145K |
|
Similar funds
Barclays's Q2 2018 Portfolio in Review
As of Q2 2018, Barclays held 7,691 positions worth $116B, down 11% from $131B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Barclays withdrew a net $18.4B in Q2 2018, closing 585 positions and reducing 3,613 holdings. Its most notable exit was Time Warner Inc, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 8.6% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in Evergy worth $42M.
- Barclays's largest Q2 2018 buy was Evergy: 747,502 shares worth $42M.
- Barclays added most to State Street Industrial Select Sector SPDR ETF in Q2 2018, an estimated $244M increase.
- Barclays's biggest Q2 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.2B.
- Barclays fully exited Time Warner Inc in Q2 2018, selling an estimated $290M.
- Barclays's ten largest holdings make up 27% of its $116B portfolio in Q2 2018.
- Barclays opened 402 new positions and closed 585 in Q2 2018.
- Barclays's portfolio value fell 11% quarter-over-quarter to $116B.
Based on Barclays's 13F filing for Q2 2018, filed 14 Aug 2018.